(Q34649397)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23496668%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

title

Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23496668%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23496668%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Pawel Kalinski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23496668%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Julie Urban

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23496668%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

publication date

1 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23496668%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Vaccines

26 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23496668%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23496668%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23496668%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

page(s)

285-295

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23496668%20AND%20SRC:MED&resulttype=core&format=json

Final maturation of dendritic cells is associated with impaired responsiveness to IFN-gamma and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells.

26 February 2020

cites work

1 reference

12 December 2020

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

1 reference

12 December 2020

Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12

1 reference

12 December 2020

T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal

1 reference

12 December 2020

Strong expression of the lymphoattractant C-X-C chemokine Mig is associated with heavy infiltration of T cells in human malignant melanoma

1 reference

12 December 2020

Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction

1 reference

12 December 2020

Clinical significance of defective dendritic cell differentiation in cancer

1 reference

12 December 2020

Identification of a novel cell type in peripheral lymphoid organs of mice. IV. Identification and distribution in mouse spleen

1 reference

12 December 2020

VEGF as a mediator of tumor-associated immunodeficiency

1 reference

12 December 2020

Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells

1 reference

12 December 2020

Complementary dendritic cell-activating function of CD8+ and CD4+ T cells: helper role of CD8+ T cells in the development of T helper type 1 responses.

1 reference

12 December 2020

The role of chemokines in melanoma tumor growth and metastasis

1 reference

12 December 2020

Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells

1 reference

12 December 2020

Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets

1 reference

12 December 2020

Migration and differentiation of CD8+ T cells

1 reference

12 December 2020

Dendritic cells transfected with interleukin‐12 and pulsed with tumor extract inhibit growth of murine prostatic carcinoma in vivo

1 reference

12 December 2020

GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells

1 reference

12 December 2020

Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells

1 reference

12 December 2020

Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells

1 reference

12 December 2020

Rapid high efficiency sensitization of CD8+ T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism

1 reference

12 December 2020

Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function

1 reference

12 December 2020

Altered maturation of peripheral blood dendritic cells in patients with breast cancer.

1 reference

12 December 2020

Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients

1 reference

12 December 2020

Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors

1 reference

12 December 2020

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

12 December 2020

alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity

1 reference

12 December 2020

Immunological properties and vaccine efficacy of murine dendritic cells simultaneously expressing melanoma-associated antigen and interleukin-12.

1 reference

12 December 2020

Retinoic acid: an educational "vitamin elixir" for gut-seeking T cells

1 reference

12 December 2020

CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease

1 reference

12 December 2020

Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs.

1 reference

12 December 2020

Migration of dendritic cell based cancer vaccines: in vivo veritas?

1 reference

12 December 2020

Intratumoral COX-2 gene expression is a predictive factor for colorectal cancer response to fluoropyrimidine-based chemotherapy

1 reference

12 December 2020

Type I interferon-associated recruitment of cytotoxic lymphocytes: a common mechanism in regressive melanocytic lesions

1 reference

12 December 2020

Treatment of transplanted CT26 tumour with dendritic cell vaccine in combination with blockade of vascular endothelial growth factor receptor 2 and CTLA-4

1 reference

12 December 2020

Tumor cell loaded type-1 polarized dendritic cells induce Th1-mediated tumor immunity

1 reference

12 December 2020

Processing and presentation of tumor antigens and vaccination strategies

1 reference

12 December 2020

Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG.

1 reference

12 December 2020

Regulatory T cells, tumour immunity and immunotherapy

1 reference

12 December 2020

Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients

1 reference

12 December 2020

Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer

1 reference

12 December 2020

Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice

1 reference

12 December 2020

Inflaming the CD8+ T cell response.

1 reference

12 December 2020

Cyclooxygenase-2 inhibitor enhances the efficacy of a breast cancer vaccine: role of IDO.

1 reference

12 December 2020

Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis

1 reference

12 December 2020

1 reference

12 December 2020

Immunosuppressive strategies that are mediated by tumor cells

1 reference

12 December 2020

Polarized type-1 dendritic cells (DC1) producing high levels of IL-12 family members rescue patient TH1-type antimelanoma CD4+ T cell responses in vitro

1 reference

12 December 2020

Reversal of tumor-mediated immunosuppression

1 reference

12 December 2020

Cancer vaccines: moving beyond current paradigms

1 reference

12 December 2020

Immunotherapy for prostate cancer using antigen-loaded antigen-presenting cells: APC8015 (Provenge).

1 reference

12 December 2020

The clinical grade maturation cocktail monophosphoryl lipid A plus IFNgamma generates monocyte-derived dendritic cells with the capacity to migrate and induce Th1 polarization

1 reference

12 December 2020

Failure at the effector phase: immune barriers at the level of the melanoma tumor microenvironment

1 reference

12 December 2020

Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals

1 reference

12 December 2020

Taking dendritic cells into medicine

1 reference

12 December 2020

Helper function of memory CD8+ T cells: heterologous CD8+ T cells support the induction of therapeutic cancer immunity

1 reference

12 December 2020

Development of a potency assay for human dendritic cells: IL-12p70 production.

1 reference

12 December 2020

Memory CD8+ T cells protect dendritic cells from CTL killing

1 reference

12 December 2020

Therapeutic efficacy of antitumor dendritic cell vaccinations correlates with persistent Th1 responses, high intratumor CD8+ T cell recruitment and low relative regulatory T cell infiltration.

1 reference

12 December 2020

Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemia

1 reference

12 December 2020

Recruitment and activation of natural killer cells in vitro by a human dendritic cell vaccine

1 reference

12 December 2020

Ability of mature dendritic cells to interact with regulatory T cells is imprinted during maturation

1 reference

12 December 2020

Cancer immunotherapy by dendritic cells

1 reference

12 December 2020

Differential production of IL-23 and IL-12 by myeloid-derived dendritic cells in response to TLR agonists

1 reference

12 December 2020

Infiltrated Neutrophils Acquire Novel Chemokine Receptor Expression and Chemokine Responsiveness in Chronic Inflammatory Lung Diseases

1 reference

12 December 2020

The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology

1 reference

12 December 2020

Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines

1 reference

12 December 2020

The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis

1 reference

12 December 2020

PD-1 signaling in primary T cells

1 reference

12 December 2020

Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4

1 reference

12 December 2020

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer

1 reference

12 December 2020

Maturation pathways of dendritic cells determine TAP1 and TAP2 levels and cross-presenting function

1 reference

12 December 2020

Rethinking therapeutic cancer vaccines

1 reference

12 December 2020

Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma

1 reference

12 December 2020

Independent regulation of chemokine responsiveness and cytolytic function versus CD8+ T cell expansion by dendritic cells

1 reference

12 December 2020

Intracellular mechanisms of antigen cross presentation in dendritic cells

1 reference

12 December 2020

Blockade of programmed death ligand 1 enhances the therapeutic efficacy of combination immunotherapy against melanoma

1 reference

12 December 2020

Combination of CTL-associated antigen-4 blockade and depletion of CD25 regulatory T cells enhance tumour immunity of dendritic cell-based vaccine in a mouse model of colon cancer

1 reference

12 December 2020

Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors

1 reference

12 December 2020

PGE(2) transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells

1 reference

12 December 2020

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

1 reference

12 December 2020

TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression

1 reference

12 December 2020

Approval of Provenge Seen As First Step for Cancer Treatment Vaccines

1 reference

12 December 2020

Dendritic Cells Induce Regulatory T Cell Proliferation through Antigen-Dependent and -Independent Interactions

1 reference

12 December 2020

Adoptive therapy using antigen-specific T-cell clones

1 reference

12 December 2020

Type-1 polarized dendritic cells loaded with apoptotic prostate cancer cells are potent inducers of CD8(+) T cells against prostate cancer cells and defined prostate cancer-specific epitopes

1 reference

12 December 2020

Development trends for human monoclonal antibody therapeutics

1 reference

12 December 2020

Improved Endpoints for Cancer Immunotherapy Trials

1 reference

12 December 2020

Effect of multiple activation stimuli on the generation of Th1-polarizing dendritic cells

1 reference

12 December 2020

The dendritic cell-tumor cross-talk in cancer

1 reference

12 December 2020

Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulo

1 reference

12 December 2020

Potency of mature CD40L RNA electroporated dendritic cells correlates with IL-12 secretion by tracking multifunctional CD8(+)/CD28(+) cytotoxic T-cell responses in vitro

1 reference

12 December 2020

Clinical development of mAbs to block the PD1 pathway as an immunotherapy for cancer

1 reference

12 December 2020

Suppression of T-cell responses by tumor metabolites

1 reference

12 December 2020

White Paper on Adoptive Cell Therapy for Cancer with Tumor-Infiltrating Lymphocytes: A Report of the CTEP Subcommittee on Adoptive Cell Therapy

1 reference

12 December 2020

Helper Activity of Natural Killer Cells During the Dendritic Cell-mediated Induction of Melanoma-specific Cytotoxic T Cells

1 reference

12 December 2020

Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?

1 reference

12 December 2020

Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro

1 reference

12 December 2020

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

1 reference

12 December 2020

Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells.

1 reference

12 December 2020

Novel cancer immunotherapy agents with survival benefit: recent successes and next steps

1 reference

12 December 2020

Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission

1 reference

12 December 2020

PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment

1 reference

12 December 2020

Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy

1 reference

12 December 2020

Regulation of immune responses by prostaglandin E2

1 reference

12 December 2020

Blocking IDO activity to enhance anti-tumor immunity.

1 reference

12 December 2020

Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity

1 reference

12 December 2020

Cancer statistics, 2012

1 reference

12 December 2020

HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ.

1 reference

12 December 2020

New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer

1 reference

12 December 2020

Cancer immunotherapy via dendritic cells

1 reference

12 December 2020

Adoptive immunotherapy for cancer: harnessing the T cell response

1 reference

12 December 2020

Raising the bar: the curative potential of human cancer immunotherapy.

1 reference

12 December 2020

Advances in the treatment of metastatic melanoma: new immunomodulatory agents

1 reference

12 December 2020

Monoclonal TCR-redirected tumor cell killing.

1 reference

12 December 2020

Immunotherapy of cancer in 2012.

1 reference

12 December 2020

NF-κB hyperactivation in tumor tissues allows tumor-selective reprogramming of the chemokine microenvironment to enhance the recruitment of cytolytic T effector cells

1 reference

12 December 2020

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

1 reference

12 December 2020

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

1 reference

12 December 2020

Cancer treatment and survivorship statistics, 2012

1 reference

12 December 2020

T-cell therapy at the threshold

1 reference

12 December 2020

Key role of the positive feedback between PGE(2) and COX2 in the biology of myeloid-derived suppressor cells

1 reference

12 December 2020

Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution

1 reference

12 December 2020

Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro

1 reference

12 December 2020

Identification of a novel cell type in peripheral lymphoid organs of mice. 3. Functional properties in vivo

1 reference

12 December 2020

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

1 reference

12 December 2020

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

1 reference

12 December 2020

A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells

1 reference

12 December 2020

Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions

1 reference

12 December 2020

Dendritic cells and the control of immunity

1 reference

12 December 2020

Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation.

1 reference

12 December 2020

Identifiers

DOI

10.1586/ERV.13.22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23496668%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23496668%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

PubMed publication ID

23496668

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23496668%20AND%20SRC:MED&resulttype=core&format=json